1 – 8 of 8
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
(
- Contribution to journal › Article
- 2023
-
Mark
Neutrophil phenotypes in bronchial airways differentiate single from dual responding allergic asthmatics
(
- Contribution to journal › Article
- 2020
-
Mark
A new role for “eat me” and “don’t eat me” markers on neutrophils in asthmatic airway inflammation
(
- Contribution to journal › Letter
- 2019
-
Mark
The potential role of CD16highCD62Ldim neutrophils in the allergic asthma
(
- Contribution to journal › Letter
- 2018
-
Mark
Substance P represents a novel first-line defense mechanism in the nose
(
- Contribution to journal › Article
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Letter
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article
- 2014
-
Mark
Functional Effects of Toll-Like Receptor (TLR)3, 7, 9, RIG-I and MDA-5 Stimulation in Nasal Epithelial Cells.
(
- Contribution to journal › Article